Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Characteristics and outcome of SARS-CoV-2 infection in cancer patients

Clémence Basse, Sarah Diakite, Vincent Servois, Maxime Frelaut, Aurélien Noret, Audrey Bellesoeur, Pauline Moreau, Marie-Ange Massiani, Anne-Sophie Bouyer, Perrine Vuagnat, Sandra Malak, François-Clément Bidard, Dominique Vanjak, Irène Kriegel, Alexis Burnod, Geoffroy Bilger, Toulsie Ramtohul, Gilles Dhonneur, Carole Bouleuc, Nathalie Cassoux, Institut Curie COVID Group, Xavier Paoletti, Laurence Bozec, Paul Cottu
doi: https://doi.org/10.1101/2020.05.14.20101576
Clémence Basse
1Department of Medical Oncology, Institut Curie, Paris & Saint Cloud, France
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sarah Diakite
1Department of Medical Oncology, Institut Curie, Paris & Saint Cloud, France
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Vincent Servois
2Department of Radiology, Institut Curie, Paris, France
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Maxime Frelaut
3Department of Drug Development and Innovation, Institut Curie, Paris & Saint Cloud, France
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Aurélien Noret
1Department of Medical Oncology, Institut Curie, Paris & Saint Cloud, France
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Audrey Bellesoeur
1Department of Medical Oncology, Institut Curie, Paris & Saint Cloud, France
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Pauline Moreau
1Department of Medical Oncology, Institut Curie, Paris & Saint Cloud, France
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Marie-Ange Massiani
1Department of Medical Oncology, Institut Curie, Paris & Saint Cloud, France
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Anne-Sophie Bouyer
1Department of Medical Oncology, Institut Curie, Paris & Saint Cloud, France
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Perrine Vuagnat
1Department of Medical Oncology, Institut Curie, Paris & Saint Cloud, France
4UVSQ, Université Paris-Saclay, Saint Cloud, France
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sandra Malak
1Department of Medical Oncology, Institut Curie, Paris & Saint Cloud, France
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
François-Clément Bidard
1Department of Medical Oncology, Institut Curie, Paris & Saint Cloud, France
4UVSQ, Université Paris-Saclay, Saint Cloud, France
MD, PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Dominique Vanjak
5Infectious Diseases Unit, Institut Curie, Paris & Saint Cloud, France
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Irène Kriegel
6Department of Anesthesia, Intensive Care and Pain Medicine, Institut Curie, Paris & Saint Cloud, France
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alexis Burnod
7Supportive and Palliative Care Department, Institut Curie, Paris & Saint-Cloud, France
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Geoffroy Bilger
1Department of Medical Oncology, Institut Curie, Paris & Saint Cloud, France
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Toulsie Ramtohul
2Department of Radiology, Institut Curie, Paris, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gilles Dhonneur
6Department of Anesthesia, Intensive Care and Pain Medicine, Institut Curie, Paris & Saint Cloud, France
MD, PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Carole Bouleuc
7Supportive and Palliative Care Department, Institut Curie, Paris & Saint-Cloud, France
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nathalie Cassoux
8Department of Surgical Oncology, Institut Curie, Paris & Saint-Cloud, France
9Université de Paris, Paris, France
MD, PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Xavier Paoletti
1Department of Medical Oncology, Institut Curie, Paris & Saint Cloud, France
4UVSQ, Université Paris-Saclay, Saint Cloud, France
MD, PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Laurence Bozec
1Department of Medical Oncology, Institut Curie, Paris & Saint Cloud, France
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Paul Cottu
1Department of Medical Oncology, Institut Curie, Paris & Saint Cloud, France
MD, PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: paul.cottu@curie.fr
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Abstract

Background Concerns have emerged about the higher risk of fatal COVID-19 in cancer patients. In this paper, we review the experience of a comprehensive cancer center.

Methods A prospective registry was set up at Institut Curie at the beginning of the COVID-19 pandemic. All cancer patients with suspected or proven COVID-19 were entered and actively followed for 28 days.

Results Among 9,842 patients treated at Institut Curie between mid-March and early May 2020, 141 (1.4%) were diagnosed with COVID-19, based on RT-PCR testing and/or CT-scan. In line with our case-mix, breast cancer (40%) was the most common tumor type, followed by hematological and lung malignancies (both 13%). Patients with active cancer therapy or/and advanced cancer accounted for 88% and 69% of patients, respectively. At diagnosis, 79% of patients had COVID-19 related symptoms, with an extent of lung parenchyma involvement ≤50% in 90% of patients. Blood count variations and C-reactive protein elevation were the most common laboratory abnormalities. Antibiotics and antiviral agents were administered in 48% and 7% of patients, respectively. At the time of analysis, 26 patients (18%) have died from COVID-19, and 81 (57%) were cured. Independent prognostic factors at the time of COVID-19 diagnosis associated with death or intensive care unit admission were extent of COVID-19 pneumonia and decreased O2 saturation.

Conclusion COVID-19 incidence and presentation in cancer patients appear to be very similar to those in the general population. The outcome of COVID-19 is primarily driven by the initial severity of infection rather than patient or cancer characteristics.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

Funding This work was supported by Institut Curie, Université de Versailles Saint Quentin and Université Paris-Saclay (no grant number applicable)

Author Declarations

All relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.

Yes

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Footnotes

  • ↵** Members of the Institut Curie COVID Group are detailed in the Acknowledgements section

Data Availability

Availability of data and materials The data underlying this article cannot be shared publicly due to current French HIPAA regulations (birthdate, admission date, discharge date, date of death). Data will be shared on reasonable request to the corresponding author.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Back to top
PreviousNext
Posted May 19, 2020.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Characteristics and outcome of SARS-CoV-2 infection in cancer patients
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Characteristics and outcome of SARS-CoV-2 infection in cancer patients
Clémence Basse, Sarah Diakite, Vincent Servois, Maxime Frelaut, Aurélien Noret, Audrey Bellesoeur, Pauline Moreau, Marie-Ange Massiani, Anne-Sophie Bouyer, Perrine Vuagnat, Sandra Malak, François-Clément Bidard, Dominique Vanjak, Irène Kriegel, Alexis Burnod, Geoffroy Bilger, Toulsie Ramtohul, Gilles Dhonneur, Carole Bouleuc, Nathalie Cassoux, Institut Curie COVID Group, Xavier Paoletti, Laurence Bozec, Paul Cottu
medRxiv 2020.05.14.20101576; doi: https://doi.org/10.1101/2020.05.14.20101576
Reddit logo Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Characteristics and outcome of SARS-CoV-2 infection in cancer patients
Clémence Basse, Sarah Diakite, Vincent Servois, Maxime Frelaut, Aurélien Noret, Audrey Bellesoeur, Pauline Moreau, Marie-Ange Massiani, Anne-Sophie Bouyer, Perrine Vuagnat, Sandra Malak, François-Clément Bidard, Dominique Vanjak, Irène Kriegel, Alexis Burnod, Geoffroy Bilger, Toulsie Ramtohul, Gilles Dhonneur, Carole Bouleuc, Nathalie Cassoux, Institut Curie COVID Group, Xavier Paoletti, Laurence Bozec, Paul Cottu
medRxiv 2020.05.14.20101576; doi: https://doi.org/10.1101/2020.05.14.20101576

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Oncology
Subject Areas
All Articles
  • Addiction Medicine (269)
  • Allergy and Immunology (549)
  • Anesthesia (134)
  • Cardiovascular Medicine (1747)
  • Dentistry and Oral Medicine (238)
  • Dermatology (172)
  • Emergency Medicine (310)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (653)
  • Epidemiology (10780)
  • Forensic Medicine (8)
  • Gastroenterology (584)
  • Genetic and Genomic Medicine (2933)
  • Geriatric Medicine (286)
  • Health Economics (531)
  • Health Informatics (1918)
  • Health Policy (833)
  • Health Systems and Quality Improvement (743)
  • Hematology (290)
  • HIV/AIDS (627)
  • Infectious Diseases (except HIV/AIDS) (12496)
  • Intensive Care and Critical Care Medicine (684)
  • Medical Education (299)
  • Medical Ethics (86)
  • Nephrology (321)
  • Neurology (2780)
  • Nursing (150)
  • Nutrition (431)
  • Obstetrics and Gynecology (554)
  • Occupational and Environmental Health (597)
  • Oncology (1454)
  • Ophthalmology (440)
  • Orthopedics (172)
  • Otolaryngology (255)
  • Pain Medicine (190)
  • Palliative Medicine (56)
  • Pathology (379)
  • Pediatrics (865)
  • Pharmacology and Therapeutics (362)
  • Primary Care Research (333)
  • Psychiatry and Clinical Psychology (2630)
  • Public and Global Health (5338)
  • Radiology and Imaging (1002)
  • Rehabilitation Medicine and Physical Therapy (594)
  • Respiratory Medicine (722)
  • Rheumatology (329)
  • Sexual and Reproductive Health (288)
  • Sports Medicine (278)
  • Surgery (327)
  • Toxicology (47)
  • Transplantation (149)
  • Urology (125)